Regulus Therapeutics
RGLS
#9072
Rank
NZ$0.16 B
Marketcap
$2.57
Share price
7.25%
Change (1 day)
-34.68%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -NZ$66.79 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$51.2 Million a decrease over its 2022 earnings that were of -NZ$48.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$66.79 Million30.44%
2023 -NZ$51.2 Million6.51%
2022 -NZ$48.07 Million2.53%
2021 -NZ$46.89 Million93.59%
2020 -NZ$24.22 Million-15.41%
2019 -NZ$28.63 Million-64.46%
2018 -NZ$80.55 Million-33.26%
2017 -NZ$0.13 Billion-13.98%
2016 -NZ$0.15 Billion44.77%
2015 -NZ$96.92 Million-1.63%
2014 -NZ$98.53 Million203.6%
2013 -NZ$32.46 Million8.65%
2012 -NZ$29.87 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$7.25 B-10,182.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$13.81 B-19,298.05%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$3.31 B-4,707.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$18.14 B-25,319.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$0.41 Billion 469.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.24 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.58 Billion 20,154.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA